REG - Surgical Innovations - Director/PDMR Shareholding
RNS Number : 0361TSurgical Innovations Group PLC11 November 2019
Surgical Innovations Group plc
("SI Group" or "the Company")
Director/PDMR Shareholding
The Company was notified on 11 November 2019 that on 6 November 2019 Paul Hardy, Non-Executive Director of the Company, purchased 200,000 ordinary shares of 1 penny each in the Company ("Shares") at a price of 2.5p per Share.
Following the transaction, the combined beneficial holding of Paul Hardy is 7,108,711 Shares, representing approximately 0.89% of the issued share capital of the Company.
For further information please contact:
Surgical Innovations Group Plc
Nigel Rogers, Non-Executive Chairman
Tel: 0113 230 7597
Charmaine Day, GFC & Company Secretary
N+1 Singer (NOMAD & Broker)
Richard Lindley
Rachel Hayes
Tel: 020 7496 3000
Walbrook PR (Financial PR & Investor Relations)
Tel: 020 7933 8780 or si@walbrookpr.com
Paul McManus
Mob: 07980 541 893
1
Details of the person discharging managerial responsibilities/person closely associated
a)
Name
Paul Hardy
2
Reason for the notification
a)
Position/status
Non-Executive Director
b)
Initial notification/ Amendment
Initial Notification
3
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
Surgical Innovations Group plc
b)
LEI
2138004GHGUH3HUZE156
4
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument
Identification code
Ordinary shares of 1p
GB0004016704
b)
Nature of the transactions
Purchase of Ordinary Shares
c)
Price(s) and volume(s)
Price(s)
Volume(s)
2.5p
200,000
d)
Aggregated information
- Aggregated volume
- Price
200,000
£5,000
e)
Date of the transaction
6 November 2019
f)
Place of the transaction
London Stock Exchange, AIM
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.ENDDSHBIBDBRGBBGCB
Recent news on Surgical Innovations
See all newsREG - Surgical Innovations - Trading update
AnnouncementREG - Surgical Innovations - Update on timing of 2024 Full Year results
AnnouncementREG - Surgical Innovations - Holding(s) in Company
AnnouncementREG - Surgical Innovations Thalassa Holdings - Holding(s) in Company
AnnouncementREG - Surgical Innovations - FY24 Trading Update & & Directorship Change
Announcement